NCT03589339
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03589339
Title NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nanobiotix
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco San Francisco California 94158 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory University Atlanta Georgia 30308 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Henry Ford Cancer Institute Detroit Michigan 48202 United States Details
Christus St. Vincent Regional Cancer Center Santa Fe New Mexico 87505 United States Details
Northwell Health Manhasset New York 11030 United States Details
University of North Carolina, School of Medicine Chapel Hill North Carolina 27516 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
St Luke's University Health Network Bethlehem Pennsylvania 18015 United States Details
Sanford Cancer Center Sioux Falls South Dakota 57104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field